Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Consolidated Net Profit

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹1,885 Cr₹1,388 Cr₹715 Cr₹170 Cr₹441 Cr

What is the latest Consolidated Net Profit of NATCO PHARMA ?

The latest Consolidated Net Profit ratio of NATCO PHARMA is ₹1,885 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹1,885 Cr
Mar2024₹1,388 Cr
Mar2023₹715 Cr
Mar2022₹170 Cr
Mar2021₹441 Cr

How is Consolidated Net Profit of NATCO PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹1,885 Cr
35.81
Mar2024 ₹1,388 Cr
94.09
Mar2023 ₹715 Cr
320.76
Mar2022 ₹170 Cr
-61.44
Mar2021 ₹441 Cr -

Compare Consolidated Net Profit of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,279.9 Cr -1.4% -8.5% -44% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,622.0 Cr 2% -2.3% -12.6% Stock Analytics
DIVIS LABORATORIES ₹159,536.0 Cr -1.3% -6.2% 21.2% Stock Analytics
CIPLA ₹125,468.0 Cr -2.2% 3.6% -4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,162.0 Cr -0% -0.3% 5% Stock Analytics
DR REDDYS LABORATORIES ₹105,874.0 Cr -0.9% 4.5% -8.6% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.4%

-8.5%

-44%

SENSEX

1.1%

-0.4%

-2.2%


You may also like the below Video Courses